Prescription RequiredBevacizumab 100 mg/4 mL (Avastin) is a targeted anticancer medicine used to treat several types of advanced cancers, including colorectal, lung, kidney, ovarian, cervical, and brain cancers. It is given as an intravenous infusion and works by cutting off the blood supply that tumours need to grow, helping slow cancer progression.
| Generic name | Bevacizumab |
| Strength | 100 mg |
| Manufacturer | Roche Products |
| Package size | 1 vial of 4 ml |
| Used for | Colorectal, lung, kidney, ovarian, cervical, and brain cancers |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF). By blocking VEGF, it prevents the formation of new blood vessels that supply nutrients and oxygen to tumours. This helps slow or stop tumour growth and spread.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
